Eble, Johannes A.; McDougall, Matthew; Orriss, George L.; Niland, Stephan; Johanningmeier, Benjamin et al. (2017). Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively. PLoS Biology 15(7) , e2001492. 10.1371/journal.pbio.2001492. [PDB: 5thp] |
CMCF, CMCF-ID |
Peer-Reviewed Article |
Health |
James, Ashley K.; Dolgova, Natalia V.; Nehzati, Susan; Korbas, Malgorzata; Cotelesage, Julien J. H. et al. (2022). Molecular Fates of Organometallic Mercury in Human Brain. ACS Chemical Neuroscience 13(12) , 1756-1768. 10.1021/acschemneuro.2c00166. |
CLS-APS |
Peer-Reviewed Article |
Health |
Summers, Kelly L; Dolgova, Natalia V; Gagnon, Kenneth B; Sopasis, George J; James, Ashley K et al. (2020). PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study. Metallomics 12(12) , 1979-1994. 10.1039/d0mt00222d. |
CLS-APS |
Peer-Reviewed Article |
Health |
Simpson, R.; Varney, T. L.; Swanston, T.; Coulthard, I.; Cooper, D. M. L. et al. (2019). Investigating Past Lead Exposure in Bioarchaeological Remains with Synchrotron X-ray Fluorescence and Absorption Spectroscopy. Synchrotron Radiation News 32(6) , 11-16. 10.1080/08940886.2019.1680209. |
CLS-APS |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C
8
H
14
N
2
(SO
4
). Powder Diffraction , 1-5. 10.1017/s0885715625000545. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
27
H
30
N
2
O
2
. Powder Diffraction , 1-6. 10.1017/s0885715625100869. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C
19
H
21
N
4
O)(C
7
H
7
O
3
S)(H
2
O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
24
H
28
N
3
O
4
Cl(H
2
O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C
14
H
19
NO
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100791. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. |
BXDS-WLE |
Peer-Reviewed Article |
Health |